Digital Content 
NEWS #PharmaBuzz
21 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/biolinerx-and-ayrmid-ltd-enter-into-exclusive-license-agreement-to-commercialize-aphexda-motixafortide-through-gamida-cell-ltd-302312746.html
05 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/biolinerx-announces-oral-presentation-on-data-from-phase-1-clinical-trial-evaluating-motixafortide-for-cd34-hematopoietic-stem-cell-mobilization-for-gene-therapies-in-sickle-cell-disease-at-ash-2024-302295799.html
18 Jun 2024
// PRESS RELEASE
https://www.almacgroup.com/news/almac-pharma-services-supports-rapid-launch-of-biolinerxs-aphexda-motixafortide/
30 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/biolinerx-announces-clinical-trial-agreement-with-st-jude-childrens-research-hospital-inc-to-evaluate-motixafortide-for-cd34-hematopoietic-stem-cell-hsc-mobilization-for-gene-therapy-applications-in-sickle-cell-disease-scd-302158612.html
06 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/biolinerx-announces-poster-presentation-on-economic-model-data-for-aphexda-motixafortide-as-part-of-cd34-hematopoietic-stem-cell-mobilization-in-patients-with-multiple-myeloma-at-ispor-2024-302135166.html
17 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/biolinerx-announces-poster-presentation-on-apheresis-center-efficiency-and-cxcr4-antagonists-including-aphexda-motixafortide-in-patients-with-multiple-myeloma-at-the-asfa-2024-annual-meeting-302118663.html
LOOKING FOR A SUPPLIER?
Share